A clinical trial record update for plecanatide was logged on October 20, 2026. The trial, titled "The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)," is registered under identifier NCT02387359.
The study is listed as a Phase 3 trial. Its status has been updated to completed as of the record date. Plecanatide is an approved compound, and this trial specifically examined its use in irritable bowel syndrome with constipation, according to the registered study title.
This update reflects a change in trial status only. No results, outcomes, or efficacy conclusions are included in this record update, and none should be inferred from the completed status alone. The registry entry confirms the study has reached its completed phase without detailing specific findings.
Readers seeking further detail can consult the official clinical trial registry listing for the full study record and any future results postings. For more background on plecanatide, including its approved uses, see the compound overview.